TDAC

Translational Development Acquisition
$10.85
+$0.01 (+0.09%)Oct 28, 2026
4.7NeutralMoatMint rating

MoatMint rates Translational Development Acquisition (TDAC) 4.7 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 5.0 out of 10.

Return+8.4%5YRange $10.00 - $10.90
$11.0$10.6$10.3$9.9Dec 24Nov 25Oct 26

Key metrics

The numbers that frame TDAC today
Market cap
$209.50M
P/E (TTM)
43.4
ROIC
3.2%
Div yield
0%
52wk Low
$10.41
52wk High
$10.95

TDAC stock rating

How TDAC scores on quality, value, growth, momentum and financial health
4.7out of 10
Neutral overallFair business, full price
Quality5.0
Growth2.0
Momentum6.1
Value4.8
Financial Health5.9

Growth

Revenue and earnings trend for TDAC
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about TDAC
Is Translational Development Acquisition a good buy?
Hold. Translational Development Acquisition has mixed quality and strong momentum. The setup is mixed. Growth looks poor. That could put pressure on the long-term business case. We think Translational Development Acquisition is selling at a fair price.
What is the market capitalization of TDAC?
Translational Development Acquisition's market capitalization is $209.50M.
What is the P/E (TTM) ratio for TDAC stock?
Translational Development Acquisition's P/E (TTM) ratio is 43.4, based on trailing earnings.
What is the 52-week high for TDAC stock?
The 52-week high for Translational Development Acquisition is $10.95. The current close of $10.85 is 0.9% below that high.
What is the 52-week low for TDAC stock?
The 52-week low for Translational Development Acquisition is $10.41. The current close of $10.85 is 4.3% above that low.
Does TDAC stock pay dividends?
Translational Development Acquisition does not currently show a dividend per share in the company data.